Anson Funds Management’s Cellect Biotechnology Ltd. Warrants to Purchase ADRs APOPW Stock Holding History

Anson Funds Management’s Portfolio APOPW Stock Details APOPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-40,239	Closed	-$346K	–	59
2017 Q1	$346K	Sell	40,239 -73,108	-64%	-$75K	0.14%	34
2016 Q4	$350K	Buy	+113,347	New	+$83.9K	0.11%	50

Other funds holding APOPW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Anson Funds Management's APOPW Position: Q2 2017 in Review

Anson Funds Management sold out of Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) in Q2 2017, closing a stake of 40,239 shares — an estimated $346K sold.

Anson Funds Management first reported a position in APOPW in Q4 2016 and held it in 2 quarters. The position peaked at $350K in Q4 2016. 1 fund tracked by Wall St. Rank holds APOPW as of Q2 2017.

Anson Funds Management reported no remaining Cellect Biotechnology Ltd. Warrants to Purchase ADRs position as of Q2 2017 after selling out during the quarter.
Anson Funds Management sold 40,239 Cellect Biotechnology Ltd. Warrants to Purchase ADRs shares in Q2 2017, an estimated $346K.
Anson Funds Management first reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in Q4 2016 and held it in 2 quarters.
Anson Funds Management's Cellect Biotechnology Ltd. Warrants to Purchase ADRs position peaked at $350K in Q4 2016.
1 fund tracked by Wall St. Rank held Cellect Biotechnology Ltd. Warrants to Purchase ADRs as of Q2 2017.

Based on Anson Funds Management's 13F filing for Q2 2017, filed 14 Aug 2017.